BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

586 related articles for article (PubMed ID: 23946415)

  • 1. Sarm1-mediated axon degeneration requires both SAM and TIR interactions.
    Gerdts J; Summers DW; Sasaki Y; DiAntonio A; Milbrandt J
    J Neurosci; 2013 Aug; 33(33):13569-80. PubMed ID: 23946415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARM1-specific motifs in the TIR domain enable NAD+ loss and regulate injury-induced SARM1 activation.
    Summers DW; Gibson DA; DiAntonio A; Milbrandt J
    Proc Natl Acad Sci U S A; 2016 Oct; 113(41):E6271-E6280. PubMed ID: 27671644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARM1 activation triggers axon degeneration locally via NAD⁺ destruction.
    Gerdts J; Brace EJ; Sasaki Y; DiAntonio A; Milbrandt J
    Science; 2015 Apr; 348(6233):453-7. PubMed ID: 25908823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARM modulates MyD88-mediated TLR activation through BB-loop dependent TIR-TIR interactions.
    Carlsson E; Ding JL; Byrne B
    Biochim Biophys Acta; 2016 Feb; 1863(2):244-53. PubMed ID: 26592460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The SARM1 Toll/Interleukin-1 Receptor Domain Possesses Intrinsic NAD
    Essuman K; Summers DW; Sasaki Y; Mao X; DiAntonio A; Milbrandt J
    Neuron; 2017 Mar; 93(6):1334-1343.e5. PubMed ID: 28334607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of vincristine-induced peripheral neuropathy by genetic deletion of SARM1 in mice.
    Geisler S; Doan RA; Strickland A; Huang X; Milbrandt J; DiAntonio A
    Brain; 2016 Dec; 139(Pt 12):3092-3108. PubMed ID: 27797810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. cADPR is a gene dosage-sensitive biomarker of SARM1 activity in healthy, compromised, and degenerating axons.
    Sasaki Y; Engber TM; Hughes RO; Figley MD; Wu T; Bosanac T; Devraj R; Milbrandt J; Krauss R; DiAntonio A
    Exp Neurol; 2020 Jul; 329():113252. PubMed ID: 32087251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARM1 acts downstream of neuroinflammatory and necroptotic signaling to induce axon degeneration.
    Ko KW; Milbrandt J; DiAntonio A
    J Cell Biol; 2020 Aug; 219(8):. PubMed ID: 32609299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Context-Specific Stress Causes Compartmentalized SARM1 Activation and Local Degeneration in Cortical Neurons.
    Hinz FI; Villegas CLM; Roberts JT; Yao H; Gaddam S; Delwig A; Green SA; Fredrickson C; Adrian M; Asuncion RR; Cheung TK; Hayne M; Hackos DH; Rose CM; Richmond D; Hoogenraad CC
    J Neurosci; 2024 Jun; 44(24):. PubMed ID: 38692735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of SARM1 and DR6 in retinal ganglion cell axonal and somal degeneration following axonal injury.
    Fernandes KA; Mitchell KL; Patel A; Marola OJ; Shrager P; Zack DJ; Libby RT; Welsbie DS
    Exp Eye Res; 2018 Jun; 171():54-61. PubMed ID: 29526794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NMNAT1 inhibits axon degeneration via blockade of SARM1-mediated NAD
    Sasaki Y; Nakagawa T; Mao X; DiAntonio A; Milbrandt J
    Elife; 2016 Oct; 5():. PubMed ID: 27735788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of Sarm1 does not suppress motor neuron degeneration in the SOD1G93A mouse model of amyotrophic lateral sclerosis.
    Peters OM; Lewis EA; Osterloh JM; Weiss A; Salameh JS; Metterville J; Brown RH; Freeman MR
    Hum Mol Genet; 2018 Nov; 27(21):3761-3771. PubMed ID: 30010873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TIR-1/SARM1 inhibits axon regeneration and promotes axon degeneration.
    Czech VL; O'Connor LC; Philippon B; Norman E; Byrne AB
    Elife; 2023 Apr; 12():. PubMed ID: 37083456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARM1 is responsible for calpain-dependent dendrite degeneration in mouse hippocampal neurons.
    Miyamoto T; Kim C; Chow J; Dugas JC; DeGroot J; Bagdasarian AL; Thottumkara AP; Larhammar M; Calvert ME; Fox BM; Lewcock JW; Kane LA
    J Biol Chem; 2024 Feb; 300(2):105630. PubMed ID: 38199568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vincristine and bortezomib use distinct upstream mechanisms to activate a common SARM1-dependent axon degeneration program.
    Geisler S; Doan RA; Cheng GC; Cetinkaya-Fisgin A; Huang SX; Höke A; Milbrandt J; DiAntonio A
    JCI Insight; 2019 Sep; 4(17):. PubMed ID: 31484833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple domain interfaces mediate SARM1 autoinhibition.
    Shen C; Vohra M; Zhang P; Mao X; Figley MD; Zhu J; Sasaki Y; Wu H; DiAntonio A; Milbrandt J
    Proc Natl Acad Sci U S A; 2021 Jan; 118(4):. PubMed ID: 33468661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene therapy targeting SARM1 blocks pathological axon degeneration in mice.
    Geisler S; Huang SX; Strickland A; Doan RA; Summers DW; Mao X; Park J; DiAntonio A; Milbrandt J
    J Exp Med; 2019 Feb; 216(2):294-303. PubMed ID: 30642945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the CaMKII-Sarm1-ASK1-p38 MAP kinase pathway protects against axon degeneration caused by loss of mitochondria.
    Ding C; Wu Y; Dabas H; Hammarlund M
    Elife; 2022 Mar; 11():. PubMed ID: 35285800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic diversity of axon degenerative mechanisms in models of Parkinson's disease.
    Peters OM; Weiss A; Metterville J; Song L; Logan R; Smith GA; Schwarzschild MA; Mueller C; Brown RH; Freeman M
    Neurobiol Dis; 2021 Jul; 155():105368. PubMed ID: 33892050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARM1 is a metabolic sensor activated by an increased NMN/NAD
    Figley MD; Gu W; Nanson JD; Shi Y; Sasaki Y; Cunnea K; Malde AK; Jia X; Luo Z; Saikot FK; Mosaiab T; Masic V; Holt S; Hartley-Tassell L; McGuinness HY; Manik MK; Bosanac T; Landsberg MJ; Kerry PS; Mobli M; Hughes RO; Milbrandt J; Kobe B; DiAntonio A; Ve T
    Neuron; 2021 Apr; 109(7):1118-1136.e11. PubMed ID: 33657413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.